1. A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Caimi, P.F.; Eder, J.P.; Jacobsen, E.D.; Jacobson, C.A.; LaCasce, A.S.; Shipp, M.A.; Chapuy, B.; Labriola‐Tomphins, E.; Boisserie, F.; Passe, S.; Chesné, E.; Pierceall, W.; Zhi, J.; DeMario, M.; Vaishampayan, U.; Dowlati, A.; Shapiro, G.I.; Fisher, D.C.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β‐GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B‐CELL NON‐HODGKIN LYMPHOMA. (12th June 2019) Authors: Jacobson, C.A.; Redd, R.; Reynolds, C.; Fields, M.; Armand, P.; Fisher, D.C.; Jacobsen, E.D.; LaCasce, A.S.; Bose, N.; Ottoson, N.; Freedman, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides (MF): results from the MAVORIC study. (2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot-Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY. (12th June 2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot‐Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH DOSE‐ADJUSTED R‐EPOCH FOR PATIENTS WITH RICHTER'S SYNDROME (CRC‐043). (12th June 2019) Authors: Davids, M.S.; Thompson, P.A.; Rogers, K.A.; Tyekucheva, S.; Pazienza, S.; Francoeur, K.; Renner, S.K.; Bazemore, J.; Rocchio, M.; Ihuoma, U.; Jacobson, C.A.; Fisher, D.C.; Brown, J.R. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL. (June 2017) Authors: Davids, M.S.; Kim, H.T.; Nicotra, A.; Savell, A.; Francoeur, K.; Hellman, J.M.; Miskin, H.; Sportelli, P.; Bashey, A.; Stampleman, L.; Rueter, J.; Boruchov, A.; Arnason, J.E.; Jacobson, C.A.; Jacobsen, E.J.; Fisher, D.C.; Brown, J.R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗